{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T17:01:27Z","timestamp":1774285287218,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-026-01419-9","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T08:25:23Z","timestamp":1771057523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Peer-led drug checking in Chile: a case study of the country\u2019s first harm reduction service at electronic music events"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2125-1417","authenticated-orcid":false,"given":"Camilo","family":"Obreg\u00f3n-Berg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8886-7160","authenticated-orcid":false,"given":"Bruno","family":"Fuentealba-Donoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidora","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8463-6473","authenticated-orcid":false,"given":"Javiera","family":"Navarrete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"key":"1419_CR1","unstructured":"Canadian Public Health Association. Framework for a public health approach to substance use. Ottawa, ON: Canadian Public Health Association., 2024 January 2024. https:\/\/www.cpha.ca\/framework-public-health-approach-substance-use."},{"key":"1419_CR2","unstructured":"Organization of American States (OAS); Inter-American Drug Abuse Control Commission (CICAD). Report on drug supply in the Americas 2022 [online]. 2022. https:\/\/oas.org\/en\/sms\/cicad\/docs\/CICAD_Report_on_Drug_Supply_in_the_Americas_2022.pdf."},{"key":"1419_CR3","unstructured":"Organization of American States (OAS); Secretariat for Multidimensional Security (SMS); Inter-American Drug Abuse Control Commission (CICAD). Report on drug use in the Americas 2019 [online]. 2019. https:\/\/idpc.net\/publications\/2020\/01\/report-on-drug-use-in-the-americas."},{"key":"1419_CR4","unstructured":"Jason E. Global synthetic drug markets - The present and future. Global initiative against transnational organized crime; 2024. https:\/\/globalinitiative.net\/wp-content\/uploads\/2024\/03\/Jason-Eligh-Global-synthetic-drug-markets-The-present-and-future-GI-TOC-March-2024.pdf."},{"key":"1419_CR5","unstructured":"United Nations Office on Drugs and Crime. Drug market patterns and trends [online]. 2024. https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/wdr2024-drug-market-trends.html."},{"issue":"2","key":"1419_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0955-3959(02)00007-5","volume":"13","author":"T Rhodes","year":"2002","unstructured":"Rhodes T. The \u2018risk environment\u2019: a framework for Understanding and reducing drug-related harm. Int J Drug Policy. 2002;13(2):85\u201394. https:\/\/doi.org\/10.1016\/S0955-3959(02)00007-5.","journal-title":"Int J Drug Policy"},{"key":"1419_CR7","unstructured":"United Nations Office on Drugs and Crime. World drug report 2024. Vienna, Austria. 2024. https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/wdr2024-key-findings-conclusions.html."},{"key":"1419_CR8","unstructured":"De los Rios Hernandez I. Knowledge, soil, politics, and poverty: how drug trafficking has kept its hold on Latin America [online]. 2024. https:\/\/hir.harvard.edu\/knowledge-soil-politics-and-poverty-how-drug-trafficking-has-kept-its-hold-on-latin-america\/."},{"key":"1419_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/add.70031","author":"A Castillo-Carniglia","year":"2025","unstructured":"Castillo-Carniglia A. National profile on substance use, substance use-related problems and policy: the case of Chile. Addiction. 2025. https:\/\/doi.org\/10.1111\/add.70031.","journal-title":"Addiction"},{"key":"1419_CR10","unstructured":"Servicio Nacional para la Prevenci\u00f3n y Rehabilitaci\u00f3n del Consumo de Drogas y Alcohol. Estrategia nacional de drogas 2021\u20132030. Para un Chile que elige vivir sin drogas. Santiago, Chile: Ministerio del Interior y Seguridad P\u00fablica, Gobierno de Chile. 2021. https:\/\/www.senda.gob.cl\/wp-content\/uploads\/2021\/02\/Estrategia-Nacional-de-Drogas-version-web.pdf (accessed July 29, 2025)."},{"key":"1419_CR11","unstructured":"Servicio Nacional para la Prevenci\u00f3n y Rehabilitaci\u00f3n del Consumo de Drogas y Alcohol. D\u00e9cimo quinto estudio nacional de drogas en poblaci\u00f3n general de Chile. 2022. Ministerio del Interior y Seguridad P\u00fablica, Gobierno de Chile; 2024. https:\/\/bibliodrogas.gob.cl\/wp-content\/uploads\/2024\/11\/ENPG-2022-OK.pdf (accessed July 29, 2025)."},{"issue":"5","key":"1419_CR12","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1080\/00952990.2023.2207716","volume":"49","author":"JJ Palamar","year":"2023","unstructured":"Palamar JJ. Tusi: a new ketamine concoction complicating the drug landscape. Am J Drug Alcohol Abuse. 2023;49(5):546\u201350. https:\/\/doi.org\/10.1080\/00952990.2023.2207716.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"1419_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1108\/dhs-07-2022-0026","volume":"23","author":"M D\u00edaz Moreno","year":"2022","unstructured":"D\u00edaz Moreno M, Alarc\u00f3n Ayala N, Estrada Y, et al. \u00c9chele Cabeza as a harm reduction project and activist movement in Colombia. Drugs Habits Social Policy. 2022;23(3):263\u201376. https:\/\/doi.org\/10.1108\/dhs-07-2022-0026.","journal-title":"Drugs Habits Social Policy"},{"key":"1419_CR14","doi-asserted-by":"publisher","unstructured":"Castaldelli-Maia JM, Wang Y-P, Brunoni AR, et al. Burden of disease due to amphetamines,cannabis, cocaine, and opioid use disorders in South America, 1990\u20132019: a systematic analysis of the Global Burden of Disease Study 2019. The Lancet Psychiatry 2023;10(2):85\u201397. https:\/\/doi.org\/10.1016\/S2215-0366(22)00339-X.","DOI":"10.1016\/S2215-0366(22)00339-X"},{"key":"1419_CR15","doi-asserted-by":"publisher","unstructured":"Chen Y, Shiels MS, Thomas D, et al. Premature mortality from drug overdoses: a comparative analysis of 13 organisation for economic co-operation and development member countries with high-quality death certificate data, 2001 to 2015.Ann Intern Med. 2019;170(5):352\u20134. https:\/\/doi.org\/10.7326\/m18-2415.","DOI":"10.7326\/m18-2415"},{"issue":"3","key":"1419_CR16","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/add.15734","volume":"117","author":"N Maghsoudi","year":"2022","unstructured":"Maghsoudi N, Tanguay J, Scarfone K, et al. Drug checking services for people who use drugs: a systematic review. Addiction. 2022;117(3):532\u201344. https:\/\/doi.org\/10.1111\/add.15734.","journal-title":"Addiction"},{"issue":"1","key":"1419_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12954-023-00924-5","volume":"21","author":"KJ Moon","year":"2024","unstructured":"Moon KJ, Whitehead HD, Trinh A, et al. Enhancing drug checking services for supply monitoring: perspectives on implementation in syringe service programs in the USA. Harm Reduct J. 2024;21(1):11. https:\/\/doi.org\/10.1186\/s12954-023-00924-5.","journal-title":"Harm Reduct J"},{"key":"1419_CR18","unstructured":"Trans European Drug Information. TEDI guidelines, drug checking methodology. 2022. https:\/\/tedinetwork.org\/wp-content\/uploads\/2023\/10\/TEDI_Guidelines_A5.pdf (accessed October 31, 2025)."},{"key":"1419_CR19","doi-asserted-by":"publisher","unstructured":"Dunham K, Macon EC, Joseph R et al. \u2018I wanna know what i\u2019m putting in my body\u2019: perceptions of drug checking services and supply information among people who use drugs in Rhode Island. Drug and Alcohol Review. https:\/\/doi.org\/10.1111\/dar.70026","DOI":"10.1111\/dar.70026"},{"issue":"6","key":"1419_CR20","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1111\/dar.70003","volume":"44","author":"C Puljevi\u0107","year":"2025","unstructured":"Puljevi\u0107 C, Pocuca N, Dakin BC, et al. It\u2019d be nice to know if you\u2019re about to have drain cleaner\u2019: A qualitative study of preferred drug checking service features to inform the design of CheQpoint, queensland\u2019s first Fixed-Site drug checking service. Drug Alcohol Rev. 2025;44(6):1772\u201385. https:\/\/doi.org\/10.1111\/dar.70003.","journal-title":"Drug Alcohol Rev"},{"issue":"11","key":"1419_CR21","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2105\/AJPH.2024.307862","volume":"114","author":"J Friedman","year":"2024","unstructured":"Friedman J. Tracking drug overdose in Latin america: the epidemiological potential of prehospital and emergency department data. Am J Public Health. 2024;114(11):1153\u20135. https:\/\/doi.org\/10.2105\/AJPH.2024.307862.","journal-title":"Am J Public Health"},{"key":"1419_CR22","unstructured":"Harm Reduction International. Regional overview: Latin America and the Caribbean. 2022. https:\/\/hri.global\/wp-content\/uploads\/2022\/11\/GSHR-2022_Latin-America-and-the-Caribbean.pdf."},{"issue":"3","key":"1419_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0379-0738(99)00235-2","volume":"109","author":"CL O\u2019Neal","year":"2000","unstructured":"O\u2019Neal CL, Crouch DJ, Fatah AA. Validation of twelve chemical spot tests for the detection of drugs of abuse. Forensic Sci Int. 2000;109(3):189\u2013201. https:\/\/doi.org\/10.1016\/S0379-0738(99)00235-2.","journal-title":"Forensic Sci Int"},{"issue":"3","key":"1419_CR24","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1108\/DHS-01-2022-0007","volume":"23","author":"MJ Barratt","year":"2022","unstructured":"Barratt MJ, Measham F. What is drug checking, anyway? Drugs Alcohol Today. 2022;23(3):176\u201387. https:\/\/doi.org\/10.1108\/DHS-01-2022-0007.","journal-title":"Drugs Alcohol Today"},{"issue":"1","key":"1419_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/02791072.2022.2028203","volume":"55","author":"F Giulini","year":"2023","unstructured":"Giulini F, Keenan E, Killeen N, et al. A systematized review of Drug-checking and related considerations for implementation as A harm reduction intervention. J Psychoact Drugs. 2023;55(1):85\u201393. https:\/\/doi.org\/10.1080\/02791072.2022.2028203.","journal-title":"J Psychoact Drugs"},{"issue":"1","key":"1419_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1556-4029.2006.00331.x","volume":"52","author":"JA Morris","year":"2007","unstructured":"Morris JA. Modified Cobalt thiocyanate presumptive color test for ketamine hydrochloride. J Forensic Sci. 2007;52(1):84\u20137. https:\/\/doi.org\/10.1111\/j.1556-4029.2006.00331.x.","journal-title":"J Forensic Sci"},{"key":"1419_CR27","unstructured":"\u00c9chele C. Fentanilo y tussi, en d\u00f3nde estamos parados? [online]. 2024. https:\/\/www.echelecabeza.com\/fentanilo-y-tussi-en-donde-estamos-parados\/."},{"key":"1419_CR28","unstructured":"Sistema de Alerta Temprana de Drogas de Chile. Fentanilo, reporte de detecci\u00f3n de mezcla de sustancias psicoactivas. 2023. https:\/\/satdrogas.gob.cl\/wp-content\/uploads\/2020\/10\/Alerta-6-Fentanilo.pdf."},{"key":"1419_CR29","doi-asserted-by":"publisher","first-page":"104942doi","DOI":"10.1016\/j.drugpo.2025.104942","volume":"145","author":"M Sep\u00falveda Galeas","year":"2025","unstructured":"Sep\u00falveda Galeas M, Escobar E, Ubiergo Scheel S, et al. Monstrous substance: \u2018Tuci\u2019, pharmacopolitical assemblages and spectral materialities. Int J Drug Policy. 2025;145:104942doi. https:\/\/doi.org\/10.1016\/j.drugpo.2025.104942.","journal-title":"Int J Drug Policy"},{"issue":"3\u20134","key":"1419_CR30","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s00213-003-1730-5","volume":"173","author":"F Schifano","year":"2004","unstructured":"Schifano F. A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities. Psychopharmacology. 2004;173(3\u20134):242\u20138. https:\/\/doi.org\/10.1007\/s00213-003-1730-5.","journal-title":"Psychopharmacology"},{"key":"1419_CR31","doi-asserted-by":"publisher","first-page":"110912doi","DOI":"10.1016\/j.clinbiochem.2025.110912","volume":"137","author":"PEM Amaral","year":"2025","unstructured":"Amaral PEM, Beane SO, Albarouki A, et al. Rising illicit drug adulterants: xylazine and levamisole. Clin Biochem. 2025;137:110912doi. https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.110912.","journal-title":"Clin Biochem"},{"issue":"1","key":"1419_CR32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1477-7517-6-30","volume":"6","author":"L Knowles","year":"2009","unstructured":"Knowles L, Buxton JA, Skuridina N, et al. Levamisole tainted cocaine causing severe neutropenia in Alberta and British Columbia. Harm Reduct J. 2009;6(1):30. https:\/\/doi.org\/10.1186\/1477-7517-6-30.","journal-title":"Harm Reduct J"},{"key":"1419_CR33","doi-asserted-by":"publisher","first-page":"596895","DOI":"10.3389\/fpsyt.2021.596895","volume":"12","author":"M Fregonese","year":"2021","unstructured":"Fregonese M, Albino A, Covino C, et al. Drug checking as strategy for harm reduction in recreational contests: evaluation of two different drug analysis methodologies. Front Psychiatry. 2021;12:596895. https:\/\/doi.org\/10.3389\/fpsyt.2021.596895.","journal-title":"Front Psychiatry"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-026-01419-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01419-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01419-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:11:23Z","timestamp":1774282283000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-026-01419-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1419"],"URL":"https:\/\/doi.org\/10.1186\/s12954-026-01419-9","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not involve human participants or animals. It is based solely on aggregated data from substances voluntarily submitted for chemical analysis. No personal or identifying information was collected, and no interaction with individuals was part of the data collection process. As such, ethical approval was not required under local or institutional guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Two of the authors (COB and IV) are board members of RD, the organization that operates the peer-led drug checking service described in this case study. The authors declare no other competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}